
Reset all filters
01 2Emergent BioSolutions Canada Inc.
02 1Hikma Canada Ltd
03 16Purdue Pharma
04 8Smart & Biggar
Reset all filters
01 42478515
02 42595043
03 42599156
04 42640339
05 82770180
06 22942611
07 13033897
Reset all filters
01 8BUPRENORPHINE HYDROCHLORIDE | NALOXONE HYDROCHLORIDE DIHYDRATE
02 3NALOXONE HYDROCHLORIDE
03 16Oxycodone Hydrochloride | Naloxone Hydrochloride
Reset all filters
01 4Extended Release Tablet
02 8Extended release tablet
03 4Extended release tablets
04 8FILM, SOLUBLE
05 2SPRAY
06 1SPRAY, METERED DOSE
Reset all filters
01 11937-08-10
02 42023-04-04
03 42026-01-17
04 42026-02-28
05 42027-01-25
06 82030-08-05
07 22035-03-16
Patent Expiration Date : 1937-08-10
Date Granted : 2024-03-26
Brand Name : KLOXXADO
Patent Number : 3033897
Filing Date : 2017-08-10
Strength per Unit : 8mg / 0.1mL
Dosage Form : SPRAY, METERED DOSE
Human Or VET : Human
Route of Administration : NASAL
Patent Expiration Date : 1937-08-10
Date Granted : 2024-03-26
Patent Expiration Date : 2026-02-28
Date Granted : 2012-05-01
Oxycodone Hydrochloride, Naloxone Hydrochloride
Brand Name : TARGIN
Patent Number : 2599156
Filing Date : 2006-02-28
Strength per Unit : 10 mg / 5 mg
Dosage Form : Extended release tablet
Human Or VET : Human
Route of Administration : Oral
Patent Expiration Date : 2026-02-28
Date Granted : 2012-05-01
Patent Expiration Date : 2027-01-25
Date Granted : 2013-03-19
Oxycodone Hydrochloride, Naloxone Hydrochloride
Brand Name : TARGIN
Patent Number : 2640339
Filing Date : 2007-01-25
Strength per Unit : 10 mg / 5 mg
Dosage Form : Extended release tablet
Human Or VET : Human
Route of Administration : Oral
Patent Expiration Date : 2027-01-25
Date Granted : 2013-03-19
Patent Expiration Date : 2026-02-28
Date Granted : 2012-05-01
Oxycodone Hydrochloride, Naloxone Hydrochloride
Brand Name : TARGIN
Patent Number : 2599156
Filing Date : 2006-02-28
Strength per Unit : 20 mg / 10mg
Dosage Form : Extended release tablets
Human Or VET : Human
Route of Administration : Oral
Patent Expiration Date : 2026-02-28
Date Granted : 2012-05-01
Patent Expiration Date : 2027-01-25
Date Granted : 2013-03-19
Oxycodone Hydrochloride, Naloxone Hydrochloride
Brand Name : TARGIN
Patent Number : 2640339
Filing Date : 2007-01-25
Strength per Unit : 20 mg / 10mg
Dosage Form : Extended release tablets
Human Or VET : Human
Route of Administration : Oral
Patent Expiration Date : 2027-01-25
Date Granted : 2013-03-19
Patent Expiration Date : 2026-02-28
Date Granted : 2012-05-01
Oxycodone Hydrochloride, Naloxone Hydrochloride
Brand Name : TARGIN
Patent Number : 2599156
Filing Date : 2006-02-28
Strength per Unit : 40 mg / 20 mg
Dosage Form : Extended release tablet
Human Or VET : Human
Route of Administration : Oral
Patent Expiration Date : 2026-02-28
Date Granted : 2012-05-01
Patent Expiration Date : 2027-01-25
Date Granted : 2013-03-19
Oxycodone Hydrochloride, Naloxone Hydrochloride
Brand Name : TARGIN
Patent Number : 2640339
Filing Date : 2007-01-25
Strength per Unit : 40 mg / 20 mg
Dosage Form : Extended release tablet
Human Or VET : Human
Route of Administration : Oral
Patent Expiration Date : 2027-01-25
Date Granted : 2013-03-19
Patent Expiration Date : 2026-02-28
Date Granted : 2012-05-01
Oxycodone Hydrochloride, Naloxone Hydrochloride
Brand Name : TARGIN
Patent Number : 2599156
Filing Date : 2006-02-28
Strength per Unit : 5 mg / 2.5 mg
Dosage Form : Extended Release Tablet
Human Or VET : Human
Route of Administration : Oral
Patent Expiration Date : 2026-02-28
Date Granted : 2012-05-01
Patent Expiration Date : 2023-04-04
Date Granted : 2010-09-28
Oxycodone Hydrochloride, Naloxone Hydrochloride
Brand Name : TARGIN
Patent Number : 2478515
Filing Date : 2003-04-04
Strength per Unit : 5 mg / 2.5 mg
Dosage Form : Extended Release Tablet
Human Or VET : Human
Route of Administration : Oral
Patent Expiration Date : 2023-04-04
Date Granted : 2010-09-28
Patent Expiration Date : 2027-01-25
Date Granted : 2013-03-19
Oxycodone Hydrochloride, Naloxone Hydrochloride
Brand Name : TARGIN
Patent Number : 2640339
Filing Date : 2007-01-25
Strength per Unit : 5 mg / 2.5 mg
Dosage Form : Extended Release Tablet
Human Or VET : Human
Route of Administration : Oral
Patent Expiration Date : 2027-01-25
Date Granted : 2013-03-19